KZIA / Kazia Therapeutics Limited - Depositary Receipt (Common Stock) - Net Long/Short Value

Kazia Therapeutics Limited - Depositary Receipt (Common Stock)

KZIA / Kazia Therapeutics Limited - Depositary Receipt (Common Stock) - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Putnam Fl Investment Management Co
Balyasny Asset Management Llc
FNY Investment Advisers, LLC
Raymond James Financial Inc
Laird Norton Trust Company, Llc
Dauntless Investment Group, LLC
Barclays Plc
Velan Capital Investment Management LP
Westside Investment Management, Inc.
Point72 Asset Management, L.P.
Rhumbline Advisers
Sequoia Financial Advisors, LLC
Allworth Financial LP
GAMMA Investing LLC
Rockefeller Capital Management L.P.
Bleichroeder LP
Royal Bank Of Canada
Stonepine Capital Management, LLC
Bnp Paribas Arbitrage, Sa
UBS Group AG
Advisor Group Holdings, Inc.
Morgan Stanley
Qube Research & Technologies Ltd
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista